1
|
Meijer RP, van Onna IE, Kok ET, Bosch R. The risk profiles of three clinical types of carcinoma in situ of the bladder. BJU Int 2010; 108:839-43. [DOI: 10.1111/j.1464-410x.2010.09898.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
2
|
LOSA A, HURLE R, LEMBO A. LOW DOSE BACILLUS CALMETTE-GUERIN FOR CARCINOMA IN SITU OF THE BLADDER: LONG-TERM RESULTS. J Urol 2000. [DOI: 10.1016/s0022-5347(05)67974-8] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- A. LOSA
- From the Division of Urology, Ospedali Riuniti di Bergamo, Bergamo, Italy
| | - R. HURLE
- From the Division of Urology, Ospedali Riuniti di Bergamo, Bergamo, Italy
| | - A. LEMBO
- From the Division of Urology, Ospedali Riuniti di Bergamo, Bergamo, Italy
| |
Collapse
|
3
|
|
4
|
Harnden P, Parkinson M. Transitional cell carcinoma of the bladder: diagnosis and prognosis. ACTA ACUST UNITED AC 1996. [DOI: 10.1016/s0968-6053(96)80014-7] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
|
5
|
Affiliation(s)
- M A Hudson
- Division of Urological Surgery, Washington University School of Medicine, St. Louis, Missouri
| | | |
Collapse
|